- 1 870
- 1 666 011
CheckRare
United States
Приєднався 14 сер 2015
Rare Diseases Are Our Focus, Expertise, and Passion.
CheckRare is a learning platform for healthcare professionals and the rare disease community. We provide expert discussions regarding rare diseases, current and emerging therapies, clinical trials, advocacy, and BioPharma companies.
CheckRare is a learning platform for healthcare professionals and the rare disease community. We provide expert discussions regarding rare diseases, current and emerging therapies, clinical trials, advocacy, and BioPharma companies.
FDA Approval of Setmelanotide for Patients 2 Years and Older With MC4R Pathway Diseases
David Meeker, MD, Chief Executive Officer of Rhythm Pharmaceuticals, discusses the U.S. Food and Drug Administration’s (FDA) approval of setmelamotide for children 2 years and older with syndromic or monogenic obesity due to Bardet-Biedl syndrome (BBS) or genetically confirmed pro-opiomelanocortin (POMC), including proprotein convertase subtilisin/kexin type 1 (PCSK1), deficiency or leptin receptor (LEPR) deficiency.
BBS, POMC, PCSK1, and LEPR deficiencies are rare melanocortin-1 receptor (MC4R) pathway diseases. Common characteristics include hyperphagia, impaired satiety, persistent and abnormal food-seeking behaviors, and early-onset obesity.
Setmelanotide, or Imcivree, is an MC4R agonist that targets the impairment in the hypothalamic MC4R pathway. Activation of this pathway helps increase satiety signals and energy expenditure.
The approval follows results of clinical trials where setmelanotide was observed to significantly and sustainably reduce measures of weight and hunger. Safety and tolerability has also been favorable, with common adverse events being skin hyperpigmentation, injection site reactions, diarrhea, nausea, and headache.
The treatment was originally approved in November 2020 for patients 6 years and older with POMC, PCSK1, and LEPR deficiencies, and June 2022 for patients with BBS.
Chapters:
MC4R Pathway Diseases Overview 00:00
Differences From Prader-Willi Syndrome 3:01
Diagnosis and Genetic Testing 3:57
Setmelanotide Overview 8:04
Clinical Trials 9:53
BBS, POMC, PCSK1, and LEPR deficiencies are rare melanocortin-1 receptor (MC4R) pathway diseases. Common characteristics include hyperphagia, impaired satiety, persistent and abnormal food-seeking behaviors, and early-onset obesity.
Setmelanotide, or Imcivree, is an MC4R agonist that targets the impairment in the hypothalamic MC4R pathway. Activation of this pathway helps increase satiety signals and energy expenditure.
The approval follows results of clinical trials where setmelanotide was observed to significantly and sustainably reduce measures of weight and hunger. Safety and tolerability has also been favorable, with common adverse events being skin hyperpigmentation, injection site reactions, diarrhea, nausea, and headache.
The treatment was originally approved in November 2020 for patients 6 years and older with POMC, PCSK1, and LEPR deficiencies, and June 2022 for patients with BBS.
Chapters:
MC4R Pathway Diseases Overview 00:00
Differences From Prader-Willi Syndrome 3:01
Diagnosis and Genetic Testing 3:57
Setmelanotide Overview 8:04
Clinical Trials 9:53
Переглядів: 147
Відео
Caplacizumab Combination Therapy in Patients With Acquired Thrombotic Thrombocytopenic Purpura
Переглядів 9916 годин тому
Alix Arnaud, Director of Health Economic and Value Assessment BP at Sanofi, discusses the effects of caplacizumab combination therapy in patients with acquired thrombotic thrombocytopenic purpura (TTP). TTP is a rare blood disorder characterized by low platelets, small areas of bleeding under the skin, low red blood cell count, and hemolytic anemia. TTP causes blood clots to form in small blood...
Cost Comparison of Therapies for Major Surgeries in Patients With Hemophilia A
Переглядів 8516 годин тому
Alix Arnaud, Director of Health Economic and Value Assessment BP at Sanofi, discusses the cost of efanesoctocog alfa compared with other Factor VIII replacement therapies for major surgeries in patients with hemophilia A. Hemophilia A is an inherited bleeding disorder in which the blood does not clot normally. People with hemophilia A will bleed more than normal after an injury, surgery, or den...
EMPEROR Clinical Trial for Pediatric Patients With Dravet Syndrome
Переглядів 15916 годин тому
Kelly Knupp, MD, Pediatric Epileptologist at the University of Colorado, discusses the phase 3 EMPEROR clinical trial for pediatric patients with Dravet syndrome. Dravet syndrome is the most severe of a group of conditions known as SCN1A-related seizure disorders. Symptoms include seizures which first occur in infancy that are often triggered by high temperatures. In childhood, many types of se...
Experiences of Women of Childbearing Age With Epilepsy
Переглядів 10216 годин тому
Gus Baker, PhD, International Bureau for Epilepsy, discusses a social media listening study looking at the experiences of women of childbearing age with epilepsy. A social media listening study was conducted to identify key topics of conversation, unmet needs, and emotions of women of childbearing age with epilepsy related to their motherhood journeys. A total of 245,00 posts across various soc...
The Burden of Prolonged Seizures in Patients With Epilepsy
Переглядів 10816 годин тому
Danya Kaye, UCB Pharma, discusses a study observing the profound burden of prolonged seizures in patients with epilepsy. The objective of this study was to explore the experiences of people with epilepsy living with prolonged seizures and their caregivers, identify unmet needs, determine greatest areas of burden, and assess the impact of their condition on quality of life. Prolonged seizures ar...
FDA Approval: Crinecerfont for Congenital Adrenal Hyperplasia
Переглядів 15216 годин тому
Dina Matos, Executive Director of the CARES Foundation, discusses the recent approval of crinecerfont to treat patients with congenital adrenal hyperplasia (CAH) by the U.S. Food and Drug Administration (FDA). CAH refers to a group of genetic conditions that affect the adrenal glands. Affected people lack an enzyme the adrenal glands need to make one or more of these hormones and often overprod...
Inhaled Alprazolam Versus Oral Alprazolam for Acute Seizures
Переглядів 15616 годин тому
Hugues Chanteaux, PhD, Quantitative Clinical Pharmacology Lead at UCB, discusses results from a study evaluating two different routes of alprazolam administration, inhaled (“Staccato") versus oral administration in patients with acute seizures. NCT05626439 was a phase 1, single center, open-label, randomized, single-dose, 2-way crossover study evaluating Staccato alprazolam 2 mg versus oral alp...
Topline Results of the Honeycomb Trial for GRIN-related Neurodevelopmental Disorders
Переглядів 18216 годин тому
Michael Panzara, MD, Chief Medical Officer at Neurvati Neurosciences and GRIN Therapeutics, discusses topline results of the Honeycomb trial for GRIN-related neurodevelopmental disorder with gain-of-function (GoF) variants. GRIN-related neurodevelopmental disorders are a family of rare genetic conditions caused by pathogenic mutations in the GRIN gene. These disorders are characterized by child...
EMA Pathway to Approval for Mavorixafor to Treat Patients with WHIM Syndrome
Переглядів 16716 годин тому
Paula Ragan, President and Chief Executive Officer of X4 Pharmaceuticals, discusses the pathway of approval under the European Medicines Agency (EMA) for mavorixafor for patients with WHIM syndrome. WHIM syndrome is an acronym for a rare immunodeficiency disorder with each letter representing a predominant feature of the condition: warts, hypogammaglobulinemia, infections, and myelokathexis. Sy...
Improving Health Equity in Hereditary Angioedema (HAE): A Panel Discussion (Full Program)
Переглядів 120День тому
This educational program is made possible by an unrestricted grant from Takeda Pharmaceuticals. Participants Aleena Banerji, MD Professor of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA. Timothy Craig, DO Tenured Professor of Medicine, Pediatrics, Biomedical Sciences and OB/GYN, Penn State University, Hershey, PA. Senior Medical Advisor Vinmec International Ho...
Overview: Improving Health Equity in HAE (Chapter 1)
Переглядів 164День тому
Participants Aleena Banerji, MD Professor of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA. Timothy Craig, DO Tenured Professor of Medicine, Pediatrics, Biomedical Sciences and OB/GYN, Penn State University, Hershey, PA. Senior Medical Advisor Vinmec International Hospital, Times City, Hanoi, Vietnam Marc Riedl, MD Professor of Medicine, University of Californi...
HAE in Rural Communities (Chapter 2)
Переглядів 87День тому
Participants Aleena Banerji, MD Professor of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA. Timothy Craig, DO Tenured Professor of Medicine, Pediatrics, Biomedical Sciences and OB/GYN, Penn State University, Hershey, PA. Senior Medical Advisor Vinmec International Hospital, Times City, Hanoi, Vietnam Marc Riedl, MD Professor of Medicine, University of Californi...
HAE and Race/Ethnicity (Chapter 3)
Переглядів 101День тому
Participants Aleena Banerji, MD Professor of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA. Timothy Craig, DO Tenured Professor of Medicine, Pediatrics, Biomedical Sciences and OB/GYN, Penn State University, Hershey, PA. Senior Medical Advisor Vinmec International Hospital, Times City, Hanoi, Vietnam Marc Riedl, MD Professor of Medicine, University of Californi...
Results From the PERSEUS Clinical Trial in Multiple Myeloma
Переглядів 17114 днів тому
Pieter Sonneveld, MD, Erasmus MC Cancer Institute, discusses results from the PERSEUS clinical trial for patients with multiple myeloma. Multiple myeloma is a bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia. The PERSEUS clinical trial is a phase 3, ra...
Optimizing Therapeutic Proteins Through PEGylation: Key Parameters and Impacts (Full Program)
Переглядів 92314 днів тому
Optimizing Therapeutic Proteins Through PEGylation: Key Parameters and Impacts (Full Program)
What Is PEGylation and Why Is It Important? (Chapter 1)
Переглядів 7614 днів тому
What Is PEGylation and Why Is It Important? (Chapter 1)
Biopharmaceutical and Immunological Properties of PEGylated Proteins (Chapter 2)
Переглядів 2214 днів тому
Biopharmaceutical and Immunological Properties of PEGylated Proteins (Chapter 2)
Chemical Conjugation of PEG (Chapter 3)
Переглядів 1614 днів тому
Chemical Conjugation of PEG (Chapter 3)
Factors Influencing Immunogenicity in Pegylated Therapeutics (Chapter 4)
Переглядів 2814 днів тому
Factors Influencing Immunogenicity in Pegylated Therapeutics (Chapter 4)
Phase 2 REVIVE Clinical Trial for Polycythemia Vera
Переглядів 19814 днів тому
Phase 2 REVIVE Clinical Trial for Polycythemia Vera
Real-World Evidence Supporting ANX005 for Patients With Guillain-Barré Syndrome
Переглядів 15914 днів тому
Real-World Evidence Supporting ANX005 for Patients With Guillain-Barré Syndrome
Results From Clinical Trials Testing rADAMTS13 for cTTP
Переглядів 19714 днів тому
Results From Clinical Trials Testing rADAMTS13 for cTTP
Five-Year Follow-Up Results of OPTIC Clinical Trial for CML
Переглядів 14614 днів тому
Five-Year Follow-Up Results of OPTIC Clinical Trial for CML
Chemotherapy Combination Treatment in Patients with Acute Myeloid Leukemia
Переглядів 14214 днів тому
Chemotherapy Combination Treatment in Patients with Acute Myeloid Leukemia
Differences in Clinical Outcomes of Black Patients With Multiple Myeloma
Переглядів 14114 днів тому
Differences in Clinical Outcomes of Black Patients With Multiple Myeloma
Combination C5 Therapy Versus Standard of Care in Paroxysmal Nocturnal Hemoglobinuria
Переглядів 14614 днів тому
Combination C5 Therapy Versus Standard of Care in Paroxysmal Nocturnal Hemoglobinuria
Results from the GLOW Clinical Trial in Chronic Lymphocytic Leukemia
Переглядів 13214 днів тому
Results from the GLOW Clinical Trial in Chronic Lymphocytic Leukemia
GMMG-HD7 Clinical Trial for Patients With Multiple Myeloma
Переглядів 14114 днів тому
GMMG-HD7 Clinical Trial for Patients With Multiple Myeloma
Clinical Trial Results for Bleximenib in Patients With Acute Leukemia
Переглядів 15714 днів тому
Clinical Trial Results for Bleximenib in Patients With Acute Leukemia
My 21 year old daughter has this. Its unbelieveable how this has changed her life. It's a monster
CMT1 here, is it possible to sign up Anywhere?
Really cool video! With a bit of SEO optimization, I’m sure your videos could reach even more people. Feel free to reach out if you want to chat about it sometime!"
James , how are you good sir ?..many year have passed maybe I was probably one of your first Congenital MG case’s possibly…-B.H.Burch 🙏🙏
50-80% prematurely die????
This is so real. Only our second has galactosemia but all 6 of us eat dairy free. And his younger brother is developmentally so much further ahead of him which is hard.
Can someone tell me-i had rashes all last summer. Went to dr got cream then when to skin dr got a diff cream. Ddnt seem to work. I attributed it to heat rash- driving to houston texas every other week-& being in the folds of skin, groin, breast, stomach etc. it went away over winter now. Just stumbled upon this condition this morning. Does this rash ever leave? Do i need to check into this disease?
Hello, my grandaughter was diagnosed with Grin 2B and I have a lot of questions that I would like to have an answer if possible. Can you help me?
Hi Sir. I need this Vosoritide for my son age 14year. Please how to contact you
Fellow Human with SMA Type 3 here! This is so exciting to hear especially what the higher dosage are going to do. Science!!
Hi
i would like to take part in the trial
Thanks for the detail of the emotional toll of our journey. It took 30 years to diagnose one of my conditions and 65 years to diagnose another condition. I understand. I'm now trying to get evaluated for MG. I suspect I have MG although I am 72 now. I actually already have 40 other diagnoses. A lot of them are likely connected to MG. My hands don't work on and off and my diaphragm is so weak that I feel like I can't breath after 10 minutes laying down at night. You're right that whether we are sad or happy it spikes my symptoms. Every day I wake up I never know what new symptom I will face or what old symptom has improved. I very much abhor having to find the right Neurologist. I actually went to one who forgot to meet me for my appointment! I haven't liked any of the 5 Neuros I've seen over the years and the worst are the ones who take diagnoses away. But one of the biggest problems I have is trying to navigate so many conditions at one time. I studied art not medicine! But I never quite every stop having to maintain my health. You probably feel much the same.
Sinhnaad Guggul and Gotu Kola capsules of Planet Ayurveda are very effective.
I hate it
Planet Ayurveda has very effective treatment for Scleroderma I have seen a lot of their patient's testimonials who recovered from this condition
Great to know that some treatments are being developed.
Hello. Dr sir. I am from Rawalpindi city of Pakistan. My daughter age is 4 years and she is mps-VI. Can you help me in her treatment of enzymes replacement.
Pah is what their trying to say now,for me at a clinical study place....ive been overweight and yeah im doing alot of back n forth i got a cath but a week after i had what i thought was an angina attack....im not thinking that now....but idiot me called that specialist, and brought my mother even she cant see why or what this doctor guy is all about...he didnt really answer any questions now this guy just said meds uptravi???And now ive turned it down
夫はT-LBLです。日本にいます。どうやって連絡できますか?
Thank you for this video!
Oh yeah, open mind plus scientific training equals potential vanguard results. Way to go. This is terrific. Godspeed
I’m sorry, did she say her daughter’s teeth started falling out???😅
I had a desmoid tumor in my stomach the size of a baseball. It grew into surrounding area and was not able to remove. I did three years of sorefenib (chemo in pills). The tumor also grew into my eureter and had to have my kidney removed because of it. It has been 5 years now and hasn't came back.
My 21 year old daughter had a pituitary tumor that turned out to be igg4 rd, pituitary and hypothalamus was attacked. She now has pituitary hypothyroidism, diabetes insipidus, zero sex hormones, and now also hypothalmic obesity among others. She is always starving, angry, very moody along with hot flashes etc. I'm at a loss as her mother. She is miserable and never ever satisfied. My heart breaks and I just don't know where to turn
Bu hastalığın tedavisi ilik nakli dir arkadaşlar vakit kaybetmeden iyi bir doktor bulup olun eşim bu hafta 4evre agresif mukosiz fungodes hastalığının ilik nakli olacak
I currently have a diffental diagnosis of SPS. I have been experiencing health issues since 2021. I have been out of work since November 2023 after having a small stroke. I agree with you about the doctors not listening and implying that psychotherapy is needed.
need more research on this disorder
Please do some videos DNM1 AND NSF AND AIPL1 AND NGLY1 GENE Therapys
You might just have healed me.
1:40
It's a shame that the MDA Telethon died with Jerry Lewis
I'm currently trying to get diagnosed with EDS. I'm almost 40 now, you could take the story you're telling and I'd fit it all. Everything. Started in my childhood. I had my genome done recently, I have the gene markers but have to be on a 3 yr wait list to see this Dr that can diagnose me. Between the pain in my neck and injuries to my neck, i won't be able to move by then.
45 years here. Just finally knowing has made a world of difference for me. It's like my whole life was a box of jigsaw puzzle pieces, and I'm just now seeing them all perfectly put together for the first time. Had I known this 25 years ago, I would have had a completely different life outcome. Thank you to everyone who brings awareness to this issue! 🙏🏽
Please get this drug approved for anything, so I can off label stick it in my teeth.
And it started flaring up because of a medication called in Vegas
I believe I have all the symptoms for disease syrup my childhood as far as different things reasons I should tell my doctor Methylmalonic acidemia (MMA) is a rare genetic disorder that affects the body's ability to break down certain fats and proteins. The condition typically presents with different signs and symptoms, which can vary in severity. Here are some common ones: 1. Vomiting and Feeding Problems: Frequent vomiting and difficulty feeding are common, especially in infants. 2. Muscle Weakness and Lethargy: Affected individuals might exhibit muscle weakness or appear unusually tired. 3. Failure to Thrive: Infants might grow more slowly than normal. 4. Developmental Delays: Delays in reaching developmental milestones might occur. 5. Respiratory Distress: Problems with breathing can be a symptom. 6. Metabolic Crises: Episodes characterized by hypotonia (reduced muscle tone), lethargy, and metabolic acidosis can occur. 7. Seizures: Some individuals may experience seizures. 8. Neurological Symptoms: This can include poor coordination or movement problems. 9. Anemia: Some may develop anemia due to the body's difficulty in getting enough oxygen to its tissues. 10. Recurrent Infections: Due to the impact on the immune system, there may be a tendency towards getting frequent infections. This condition requires medical diagnosis and management, typically by specialists in metabolic disorders, to help manage the symptoms and reduce the risk of complications.
Methylmalonic acidemia (MMA) is a rare genetic disorder that affects the body's ability to break down certain fats and proteins. The condition typically presents with different signs and symptoms, which can vary in severity. Here are some common ones: 1. Vomiting and Feeding Problems: Frequent vomiting and difficulty feeding are common, especially in infants. 2. Muscle Weakness and Lethargy: Affected individuals might exhibit muscle weakness or appear unusually tired. 3. Failure to Thrive: Infants might grow more slowly than normal. 4. Developmental Delays: Delays in reaching developmental milestones might occur. 5. Respiratory Distress: Problems with breathing can be a symptom. 6. Metabolic Crises: Episodes characterized by hypotonia (reduced muscle tone), lethargy, and metabolic acidosis can occur. 7. Seizures: Some individuals may experience seizures. 8. Neurological Symptoms: This can include poor coordination or movement problems. 9. Anemia: Some may develop anemia due to the body's difficulty in getting enough oxygen to its tissues. 10. Recurrent Infections: Due to the impact on the immune system, there may be a tendency towards getting frequent infections. This condition requires medical diagnosis and management, typically by specialists in metabolic disorders, to help manage the symptoms and reduce the risk of complications.
Can't hear what is being said but thank you for trying to provide information on Mycosis fungoides.
Thanks for this video! I have had narcolepsy and ADHD since I was 12. I'm 26 now and it has been hell but I'm looking forward to trying Lumyrz, stimulants only made my sleep quality worse and increased my need for naps in the day, it just doesn't work as much as it helps when it's working.
Mark, Thank you for the information and for working on Pemgarda. There are a number of compromised individuals like myself who have a week immune system not caused by disease or medicine. In my case, I have a seriously low white blood cell count. My lymphocyte counts are less than half the minimum. Consequently, the covid vaccine is less likely to mount a strong defense. Half the people who have my condition have it for no known reason. I have had this condition for at least 10 years when my doctors first did a CBC blood test. I am currently reaching out to my doctors in the NY area to get a prescription for Pemgarda but have not been successful thus far. There is a underlying resistance to writing prescriptions for IV treatments. I'm committed to getting it though. I'll keep you posted. Thank you for an intelligent, polished and thoughtful video.
Trying to advocate for my bf right now . He got possible diagnosis from neurology . Sent for blood work and then his family doctor called back and said no you don’t have it . I have done nothing but research since finding out and I turkey believe he does .
5 years down the line, gene therapy is still very costly.
1.6 mg/kg/d what does this mean? If i calculate rightly 1.6 mg per kg will be 80MG for a 52KG person? Isnt this too high?
My son was just diagnosed with SPS. He was lucky enough to live in the Chicago metropolitan area of the US. My husband and I are lucky enough we don’t live too far from them. He started having symptoms in April 2024. He’s been having major issues including affecting his breathing. He is 40 years old. His wife is wonderful. I’ve been trying to find out about the disease and treatments. His doctors are just trying to get the flares calmed down and getting a treatment plan in place. I must say hearing you talk makes me very scared. He works as an architect and project manager I. Downtown Chicago. They’ve made a medical accommodation and allowed him to work from home home for the next year and then reassess to see how it’s going.
My disease is also Fibrodysplasia ossificans progressiva😢😢. My age is 33
What a great mom
I have this. I consider it an autoimmune disorder. It’s been about 20 years since it started plus 15 years of being a childhood asthmatic. The problem is entirely caused by allergens. It’s extremely difficult or impossible to avoid allergens entirely. Besides that I’m still not totally sure of what I am or am not allergic to. Some things for sure I’m allergic to are animals with fur, marijuana, wheat food, dust, beer, nuts. Basically it causes endless burping, asthmatic symptoms, stomach contents moving upwards, chest pain, high blood pressure. The condition is potentially life threatening due to the increased pressure on the heart over long periods of time. The disease only affects me as noted. I’m otherwise healthy able and normal. I don’t know for sure but I believe the condition is a result of a childhood virus or illness.
Where is your hospotal
Hello I am ajesh a fshd patient from India. Happy to hear the development of del brax. At last l am happy to see the light in the tunnel.Next question is will it be affordable for people like me from countries like India..